Cel-Sci
CVM
#9766
Rank
A$78.04 M
Marketcap
A$9.76
Share price
2.54%
Change (1 day)
-62.52%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of June 2025 : A$30.78 Million

According to Cel-Sci 's latest financial reports the company's total assets are A$30.78 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-09-30A$39.02 M-17.82%
2023-09-30A$47.49 M-39.54%
2022-09-30A$78.55 M-25.13%
2021-09-30A$0.10 B85.49%
2020-09-30A$56.56 M38.28%
2019-09-30A$40.9 M-0.13%
2018-09-30A$40.95 M40.17%
2017-09-30A$29.21 M-10.32%
2016-09-30A$32.58 M-20.01%
2015-09-30A$40.73 M85.07%
2014-09-30A$22 M89.27%
2013-09-30A$11.62 M-25.05%
2012-09-30A$15.51 M-18.85%
2011-09-30A$19.11 M-51.23%
2010-09-30A$39.19 M-26.04%
2009-09-30A$53 M185.95%
2008-09-30A$18.53 M-20.03%
2007-09-30A$23.17 M79.13%
2006-09-30A$12.94 M217.79%
2005-09-30A$4.07 M-47.06%
2004-09-30A$7.69 M79.05%
2003-09-30A$4.29 M-38.07%
2002-09-30A$6.93 M-24.33%
2001-09-30A$9.16 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Curis
CRIS
A$41.83 M 35.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.67 B 2,095.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$136.44 B 443,153.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.31 B 4,172.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$60.32 B 195,885.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
A$291.86 B 948,041.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.21 B 7,084.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$9.34 M-69.65%๐Ÿ‡บ๐Ÿ‡ธ USA